This inventor holds 1 USPTO granted patent. Top assignee: Probiodrug Ag. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Susanne Aust: Innovator in Cognitive Disease Treatment
Introduction
Susanne Aust is a prominent inventor based in Halle, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for cognitive diseases. Her work focuses on creating innovative solutions that address critical health challenges.
Latest Patents
One of her notable patents is titled "Inhibitors of prolyl endopeptidase." This invention relates to novel inhibitors of prolyl endopeptidase, which are useful for treating diseases such as mild cognitive impairment (MCI), Alzheimer's disease, Down Syndrome, Parkinson's disease, and Chorea Huntington. The patent includes specific compounds defined by the formula (1), where I, A, X, Y, and Z are detailed in the description. Susanne holds 1 patent in this area.
Career Highlights
Susanne Aust is associated with Probiodrug AG, a company dedicated to developing innovative therapies for neurodegenerative diseases. Her role at the company has allowed her to leverage her expertise in medicinal chemistry to advance research and development efforts.
Collaborations
Throughout her career, Susanne has collaborated with notable colleagues, including Hans-Ulrich Demuth and Andre Johannes Niestroj. These partnerships have contributed to her success and the advancement of her research initiatives.
Conclusion
Susanne Aust is a key figure in the field of cognitive disease treatment, with her innovative patents paving the way for new therapeutic options. Her work continues to impact the lives of those affected by neurodegenerative diseases.